Current position:Home >Product >
ethyl 5-(2-ethyl-4-oxoquinazolin-3(4H)-yl)-1-methyl-1H-pyrazole-4-carboxylate
ethyl 5-(2-ethyl-4-oxoquinazolin-3(4H)-yl)-1-methyl-1H-pyrazole-4-carboxylate(104907-82-6)
- Name: ethyl 5-(2-ethyl-4-oxoquinazolin-3(4H)-yl)-1-methyl-1H-pyrazole-4-carboxylate
- Synonyms:
- Molecular Formula:C17H18 N4 O3
- Molecular Weight:326.355
- CAS Registry Number:104907-82-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 120465-65-8/3-butyl-7-[(2,5-dimethylphenyl)sulfonyl]-9,9-dimethyl-3,7-diazabicyclo[3.3.1]nonane 2,3-dihydroxybutanedioate (2:3) (salt)
- 56554-86-0/octadec-17-enal
- 571-45-9/Androst-4-ene-3,17-dione,(9â,10R)-
- 29718-57-8/Pyrido[1,2-a]benzimidazole-4-carboxylicacid, methoxy-1,3-dimethyl-, sodium salt (8CI)
- 146394-65-2/Cyclohexanehexanamide, g-hydroxy-a-(1-methylethyl)-N-[2-methyl-1-[[(2-pyridinylmethyl)amino]carbonyl]butyl]-d-[[2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxo-3-(phosphonooxy)butyl]amino]-,dipotassium salt, [aS-[N(1R*,2R*),aR*,gR*,dR*(2R*,3S*)]]- (9CI)
- 116425-98-0/Pregnane-3,5,6,8,12,14,17,20-octol,12,20-bis(3-phenyl-2-propenoate), (3b,5a,6b,12b,14b,17a,20S)- (9CI)
- 21906-90-1/4-(diethylamino)benzenediazonium
- 31175-20-9/NAFION(R) DISPERSION SOLUTION DE1021 CS TYPE
- 99886-25-6/9-stearyl-9-phosphabicyclo[3.3.1]nonane
- 93679-20-0/4-amino-3-(methylsulfanyl)-6-(pentan-3-yl)-1,6-dihydro-1,2,4-triazin-5(4H)-one
- 60063-19-6/Phenol,4,4'-(1-methylethylidene)bis-,polymers,polymer with (chloromethyl)oxirane,mixt. with N-[3-(trimethoxysilyl)propyl]-1,2- ethanediamine
- 36782-45-3/2-(4-Isopropylphenyl)-5-benzothiazoleacetic acid
- 104155-15-9/2-methyl-3-(2,2,2-tribromoethyl)phenol
- 94042-88-3/Thymidylyl-(3.5)-2-deoxycytidylyl-(3.5)-thymidylyl-(3.5)-2-deoxyguanylyl-(3.5)-2-deoxycytidylyl-(3.5)-2-deoxyadenylyl-(3.5)-2-deoxyguanylyl-(3.5)-2-deoxyadenosine
- 126596-43-8/ethyl 7-methyl-4-oxo-3-phenyl-2-(prop-2-en-1-ylsulfanyl)-3,4-dihydropyrido[2,3-d]pyrimidine-5-carboxylate
- 25167-62-8/DOCOSAHEXAENOIC ACID
- 7233-36-5/1-[5-(phenylselanyl)pentyl]pyrrolidine-2,5-dione
- 36937-92-5/2-(4-Cyanobenzylidene)malononitrile
- 66451-68-1/(Carboxymethyl)dimethyl(1-oxooctadecyl)ammonium hydroxide
- 104907-82-6/ethyl 5-(2-ethyl-4-oxoquinazolin-3(4H)-yl)-1-methyl-1H-pyrazole-4-carboxylate
- 80544-85-0/2-cyano-2-phenylpropanamide
- 102629-88-9/Bleomycinamide,3B-O-de(aminocarbonyl)-N1-[3-[(1-phenylethyl)amino]propyl]-, (S)- (9CI)
- 15060-62-5/NICKEL SELENATE
- 58526-49-1/Ro 8-7201
- 19536-88-0/Silicate(2-),pentafluoromethyl-,disodium,(OC-6-21)-
- 148266-08-4/Protein (human clone10-53 growth factor receptor-binding 2 reduced) (9CI)
- 91672-62-7/Chromate(2-), (3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-2-hydroxy-5-nitrobenzenesulfonato(3-))hydroxy(2,4-pentanedionato-O,O)-, ammonium sodium
- 6237-24-7/3-Nitro-9-[3-(dimethylamino)propylamino]acridine
- 145430-07-5/butyl [1-(diphenylphosphoryl)-2,2,2-trifluoro-1-(trifluoromethyl)ethyl]carbamate
- 159440-09-2/2,3-dihexadecanoyloxypropoxy-[2-[[(2S)-3-methyl-2-[[(2S)-4-methyl-2-[1 -[(2R)-2-[[(2S)-2-(2-methylpropoxycarbonylamino)-3-phenyl-propanoyl]am ino]-3-naphthalen-2-yl-propanoyl]piperidine-4-carbonyl]oxy-pentanoyl]a mino]butanoyl]amino]ethoxy]phosphinic acid